SCHEMBL10183233

SCHEMBL10183233

O=C(CN1CCCc2ccccc21)N(Cc1cccs1)C1C(=O)N(C2CCCCC2)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 6/20 0.44
▸ CHRM4 P08173 6/20 0.44
▸ CHRM1 P11229 6/20 0.44
▸ CHRM3 P20309 6/20 0.44
▸ ALDH1A1 P00352 6/20 0.41
▸ TSHR P16473 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185542 0.78 LMNA (0.39) ALDH1A1TSHRUSP2MAPTOPRM1
SCHEMBL10183828 0.77 ALDH1A1 (0.42) CHRM2CHRM1CHRM3ALDH1A1NPSR1
SCHEMBL10185675 0.77 ALDH1A1 (0.41) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10185657 0.76 IDH1 (0.47) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10183929 0.75 CHRM2 (0.43) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10184045 0.71 OPRM1 (0.42) CHRM2CHRM1CHRM3ALDH1A1NPSR1
SCHEMBL10183656 0.71 SIGMAR1 (0.39) ALDH1A1NPSR1HSD17B10GAAMEN1
SCHEMBL10183826 0.71 SMN1; SMN2 (0.43) ALDH1A1NPSR1GAAMEN1MAPT
SCHEMBL10184168 0.70 OPRM1 (0.37) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10183902 0.70 OPRM1 (0.39) ALDH1A1NPSR1GAAHPGDOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback